On November 8, 2005, Atrium Biotechnologies Inc. and its subsidiaries refinanced their bank debt, increasing their credit facilities with a lending syndicate led by National Bank Financial Inc., as lead arranger, to $125 million. The credit facilities are endowed with an accordion feature that permits the borrowers to increase the availability thereunder to an aggregate amount of $200 million. The credit facilities consist of cross-border acquisition facilities, made available to Atrium Biotechnologies Inc. in Canada and Atrium Finance 1 ULC in the U.S., that will allow the group to finance future strategic acquisitions.

The lending syndicate was represented by David Lemieux, Felix Gutierrez and Andrew Klug of Fasken Martineau in Montréal.